Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

ANVSANVS
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in ANNOVIS BIO INC

JPMORGAN CHASE & CO holds 15,219 shares of ANVS (ANNOVIS BIO INC), worth $28,307 as of 2026-Q2. The position was increased (+2.1% shares).

Current Value

$28,307

Current Shares

15,219

Total Value Change

+$9,193

Total Shares Change

+11,419

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
15,219
+2.1%
$28,3070.0%$1.86
13
2026-Q1
Unchanged
14,900
0.0%
$29,9490.0%$2.58
0
2025-Q4
Decreased
14,900
-50.0%
$51,5540.0%$3.46
0
2025-Q3
Increased
29,800
+100.0%
$61,6860.0%$2.04
23
2025-Q2
Increased
14,900
+69.3%
$32,3330.0%$2.05
20
2025-Q1
Increased
8,800
+131.6%
$13,2000.0%$1.65
19
2024-Q4
New
3,800
-
$19,1140.0%$5.08
28

Other major holders of ANVS: VOLORIDGE INVESTMENT MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used